Lifestyle Interventions Improve Cognition for At-Risk Older Adults
Significantly greater benefit on global cognition seen for structured versus self-guided intervention over two years
Stopping Menopausal Hormone Therapy May Temporarily Increase Fracture Risk
Fracture risk then decreases to levels similar to and then lower than women who have never used menopausal hormone therapy
GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA versus DPP4i users
Seniors With RSV-Linked Hospitalization Have Increased Cardiovascular Outcomes
Patients hospitalized with RSV have greater risk for subsequent heart failure events compared with patients with influenza, UTI, fracture
Allogeneic HCT Feasible in Older Patients With Myelodysplastic Syndrome
After propensity score matching, overall survival, PFS, nonrelapse mortality did not significantly differ for those 65 years and older versus younger than 65 years
Physicians Exiting Traditional Medicare Accelerated From 2010 to 2023
Rates higher during and since the pandemic, particularly among primary care physicians
Seniors With Insomnia More Vulnerable to Inflammatory Challenge-Induced Depression
Endotoxin induced increases in Profiles of Mood States depression subscale to a greater extent in those with insomnia
FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
Estimated risk ratio was lower with GLP-1 receptor agonists for those younger than 75 years, but was no different for those aged 75 years or older
ENDO: Osteoporosis Treatment Benefits Elderly Patients With Fragility Fracture
Benefits include lower incidence of all-cause mortality, hospitalizations